Setting Up a Poultry Farm

Must Read

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of Access Bank Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number which usually identifies both the bank and the branch where an account is...

List of First Bank of Nigeria Sort Codes in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...
- Advertisement -

This article will focus on the requirements on starting a poultry farm business, its market attractions and major challenges encountered while conducting business. Before setting up poultry, it is important to develop a business plan because it will aid in planning and overall efficiency.

Your business plan should include the following:

  1. Type of Poultry Bird: There are several ranges of birds to choose from. These include chicken, goose, duck, turkey etc.
  2. Areas of Interest: There is a range of business ventures in poultry farming. These include layers breeding, broilers breeding, hatchery or poultry feed. It is advised to focus on one venture as a start-up business.
  3. Location: The choice of business location is a very important factor. A location in a remote rural area will be less expensive to start a poultry business. A remote rural area is an ideal location because it is unsafe to set up a poultry farm near residential/urban areas for health reasons.
  4. Secure Starting Capital: With the location in mind, you should create a budget for your expenditures (equipment, building, land, staff costs, feeds etc.). There is a wide range of credit schemes that support agricultural projects such as the Lagos State Employment Trust Fund (LSETF), Central Bank of Nigeria (CBN) and Bank of Industry (BOI). Also, the FarmCrowdy platform creates a great opportunity for small-scale farms to generate funds.


Sample Cost Analysis For 300 Broiler Birds till Sales (3 Months & 2 Weeks)

Setting Up a Poultry Farm - Brand Spur

Cost Analysis provided by Goason Farms


A poultry bird (Broiler) consumes medications, vaccinations and feeds in the total of N2,500.00

Please Take Note of the following & changes that might occur: –
  1.  The total cost of a day-old chick till sales period is somewhere between N2,500-N2,800 depending on several factors which include deep litter or cage, weather conditions of the environment and care system.
  2. A bag of feed goes for N3,850 –N 3,950 depending on the season and has a weight of 25kg per bag.
  3. The tentative sales price are for a large order (100 birds and above), smaller quantities are sold for higher prices.

Other Major/Minor Cost

  1. Pen: Otherwise called a large ventilated space that can permit the use of cages or conversion to deep litters. Now depending on the area, there are 3 factors one must consider carefully before embarking on this venture
  • The cost of chick (which depends largely on the season)
  • The cost of feeds (which also depends on seasons)
  • The cost of Pen (This depends on the location your farm is and its proximity to the market or your customers) = (In Rural Lagos) = N100,000-N200,000/Year
  1. Transportation: This is the cost incurred during the purchasing of poultry feeds usually once a week if the purchase is up to 15 Bags and birds up to 200. Also, the need for transportation is also paramount to the purchase of sawdust for the local sawmill plant. Whilst the sawdust might be free, its movement to the farm cost up to N2,000.00 using tricycle ( popularly called Keke Marwa). Note that for proper health, it is important that the hygiene of the pen be up to standard for the sake of the birds, hence a pen must be cleaned every two days.
  2. Charcoal: This is needed for the 3 weeks they stay in the brooding room
Read Also:  MTN still maintaining the Lion’s share

Regulatory Requirements

To start a poultry farm business, you will require the following;

  1. Business Registration: Your business must be duly registered with the Corporate Affairs Commission (CAC).
  2. Local Government Food Permit and Business Permit: A food/business permit must be issued from the Environment Service Department of the LG/LCDA where the poultry farm is domiciled. The poultry farm will be inspected by health officers for health and safety compliance. Once the permit is approved, business operations can commence.
  3. Other Local Government Fees/Levies: Confirm with your local government if you require any other permits to operate within the area.
  4. Evidence of Tax Payment: The payment of tax by all businesses is a requirement of the Lagos State Government. Ensure you have photocopies of any tax payments ready for presentation when approached by authorities.
  5. Registration with Associated Industry Body: It might be useful to register with an associated industry body for example; the Poultry Association of Nigeria for information sharing and collaboration. This will be useful to overcome common challenges which will aid business growth.

Challenges of Doing Business

  1. High cost of feeds: The sourcing of quality feeds is costly and might be a major challenge to start-up businesses.
  2. Smuggling and Importation of Poultry Products: Imported poultry products are consumed and preferred by a greater population due to the low production rate of most businesses and might be cheaper to source.
  3. Bird Health: Poultry birds are very sensitive and contact diseases quite easily. Generally, they suffer from various types of viral, bacterial, fungal, nutritional and parasitic diseases. Proper and timely vaccinations are essential for keeping birds’ disease-free, healthy and productive.

Poultry farming has become one of the most lucrative businesses in Nigeria. As the Nigerian economy is dependent on the agriculture sector, poultry farming will continue to play an important role in the country.


  • LSETF Strategy, Research and Policy Unit
  • Gbenga Oluwafemi Ajana is the founder and Chief Executive Officer of Goason Farm. He holds a B.Sc. Economic degree from Houdegbe North American University; Benin Republic. He also has an advanced Certificate degree in Fundamentals of Operations Management from Sharphire Global Limited Institute.
- Advertisement -
Setting Up a Poultry Farm - Brand SpurSetting Up a Poultry Farm - Brand Spur

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Setting Up a Poultry Farm - Brand SpurSetting Up a Poultry Farm - Brand Spur

Latest News

DEBx Medical Receives CE Mark Clearance and ISO 13485 Certification for Debrichem(R), a Novel Desiccant Gel for Chemical Debridement to Initiate Healing in Infected,...

  • Debrichem(R) offers a very effective, alternative approach to chronic wound care, initiating healing in more than 90 % of cases after one application[1]
  • CE mark and ISO 13485:2016 certification are important prerequisites for upcoming launches in markets worldwide
  • Chronic wounds affect 1 - 2 % of developed countries' populations,[2] unsuccessful treatment may lead to enlargement of the wound, bone involvement or in the worst case, amputation[3]
  • Debrichem soon to be launched in Europe, Hong Kong, South Africa, New Zealand and Australia

ROTTERDAM, THE NETHERLANDS - EQS Newswire - 25 February 2021 - DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, is excited to highlight today the successful completion of the CE conformity assessment procedure for Debrichem(R). The innovative topical agent offers a superior alternative to surgical debridement, the current standard of care. Debrichem can now carry the CE mark for a medical device class IIb and has also been awarded ISO 13485:2016 certification. These certifications endorse the quality and safety of Debrichem to treat a high unmet medical need and the strength of the DEBx Medical team to achieve this quickly even in such difficult times. DEBx Medical plans first to launch Debrichem in Europe, South Africa as well as Hong Kong, New Zealand and Australia through a network of distribution partners; other markets will follow. DEBx Medical has started consultations with the FDA about the pathway to approval earlier this year.

Read Also:  IFMA Nigeria lauds Federal Government’s Handover of National Theatre

Debrichem is a topical desiccant gel for chemical wound debridement used for the treatment of chronic infected and/or necrotic wounds. This novel product desiccates (dehydrates) the biofilm and the pathogens in the wound bed, debriding the biofilm chemically instead of surgically. Surrounding healthy skin is not affected.[4] The data underlying the CE mark approval show that, after a one-time 60-second application, more than 90 % of wounds result in full granulation,1 an important step in the healing process.[5] Due to its fast action and applicability outside the surgery room, Debrichem can easily be integrated within standard wound care procedures.4

"Being granted the CE mark and ISO 13485 certification for Debrichem in less than two years after founding DEBx Medical is an exciting and important milestone. I am proud of our achievements and would like to thank the whole team involved in this huge effort," said Dr. Bertus Quint, founding CEO of DEBx Medical. "Chronic wounds are painful and debilitating and patients have very limited options for healing. With Debrichem, we set out to significantly improve this situation which is frustrating for healthcare professionals and patients alike. We believe that Debrichem has the potential to meaningfully improve health outcomes and quality of life for millions of patients worldwide."

"In my day-to-day work, I experience the patients' despair associated with chronic wounds and the doctors' frustration with their inability to provide patients long-term healing. With the current COVID-19 pandemic, the situation has been exacerbated: many of our patients are in high-risk groups - elderly, diabetic or chronic cardiovascular patients - who now cannot go to the hospital for their urgently needed treatment," said David L. Helfet, MD, Professor of Orthopaedic Surgery, Weill Cornell Medical College and Hospital for Special Surgery, New York Presbyterian Hospital. "The major advantage of Debrichem is that with a relatively simple, quick, one time application it destroys the biofilm. Removing the biofilm is absolute key to get chronic wounds to heal. Debrichem is an important step forward in the management of chronic wounds and will find its place in the standard of care in a very short time. It may even have the potential to become the new gold standard for debridement in chronic wound care."

Chronic wounds are defined as wounds that have not healed, at least in part, after 4 to 12 weeks.[6] Physiologically, healing of chronic wounds is corrupted, among other factors, by excess inflammation and a recurrent or persistent, if not drug-resistant, microbial infection, often in the biofilm on a wound bed.4 The current gold standard treatment, maintenance surgical debridement, is a painful procedure performed in a sterile environment. Surgical debridement does not reliably initiate healing of the wound but can be part of an extensive wound management program requiring patients to repeatedly come into the hospital. Not surprisingly, general quality of life is impaired in patients with chronic wounds.6 Chronic wounds are estimated to have a prevalence of up to 2 % in the general population.[7] The wound etiology has an impact on outcome, arterial ulcers and venous leg ulcers are notoriously difficult to heal. Chronic wounds are also a common comorbidity of diabetes,[8] 13 % of patients with diabetes in North America to 17 % in Belgium are suffering from chronic wounds.[9] The burden of chronic wounds to healthcare systems and society around the world is substantial, exacerbated by the high rate of amputation in especially diabetic patients which is close to 34 % for diabetic foot ulcers.8 In the UK alone, chronic wounds generated costs of GBP 5.6 bn in 2018. The total wound care costs in the UK increased annually by 8 - 9 % with chronic wounds accounting for the largest share.[10]

[1] Cogo A et al., J Wound Care 2020;29(Sup7b):63-64.
[2] Nussbaum SR et al., Value Health 2018;21:27-32.
[3] Strohal R et al., J Wound Care 2013; 22 (Suppl. 1): S1-S52.
[4] Cogo A et al., Wounds 2021;33:1-8.
[6] Olsson M et al., Wound Repair Regen 2019;27(1):114-125.
[7] Martinengo L et al., Ann Epidemiol 2019;29:8-15.
[8] McCosker L et al., Int Wound J 2019;16:84-95.
[9] Zhang P et al., Ann Med 2017;49:106-116.
[10] Guest JF et al., BMJ Open 2020;10:e045253.

The issuer is solely responsible for the content of this announcement.

About Debrichem(R)

Debrichem(R) is a disruptive new treatment option to address the infection in chronic wounds. The topical agent offers a superior alternative to surgical debridement, the current standard of care. Debrichem has been demonstrated to remove the biofilm and the pathogens from the wound bed that disrupt the onset of the natural healing process. Out of the more than 1.000 patients treated so far, more than 90 % of chronic wounds started to heal after only one treatment with Debrichem.4 The product is applied in a fast and simple, non-invasive procedure. Healthcare professionals should always consider using local anesthetics when applying the treatment. Debrichem can be used outside a surgical environment which can be particularly useful in situations, such as during the COVID-19 pandemic, where patients cannot get to hospitals to undergo surgery, avoiding long-term complications like amputation. Debrichem will be sold through a worldwide network of distributors, with the first market launches expected in Q1 2021.

About DEBx Medical

DEBx Medical B.V. is a Dutch medical technology company dedicated to revolutionizing the management of chronic wounds by enabling their healing, thereby improving the outcomes for millions of patients. DEBx Medical supports doctors and their patients from diagnosis through treatment, follow-up care, and maintenance of a healthy wound bed. The Company focuses its pipeline on targeting pathogens that corrupt wound healing, aiming to deliver affordable and effective treatment approaches that can easily be applied and implemented in daily clinical practice. Debrichem(R), DEBx Medical's first product, received a CE mark in early 2021 and will be launched in markets around the world. Debrichem offers a disruptive approach to debridement that has been demonstrated to enable healing of chronic wounds in more than 90 % of cases.

Setting Up a Poultry Farm - Brand Spur
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -Setting Up a Poultry Farm - Brand SpurSetting Up a Poultry Farm - Brand Spur